{"id":2346,"date":"2021-05-11T10:32:32","date_gmt":"2021-05-11T08:32:32","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2346"},"modified":"2026-02-02T11:03:42","modified_gmt":"2026-02-02T10:03:42","slug":"ubc-rapid","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/se\/products\/oncology\/ubc-rapid\/","title":{"rendered":"UBC Rapid"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”88f366a5-bf49-48d9-a338-ab22706b73e7″ global_colors_info=”{}”][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” custom_margin=”||0px||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”||||false|false” custom_padding_tablet=”10px||||false|false” custom_padding_phone=”0px||||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][dipi_breadcrumbs _builder_version=”4.16″ _module_preset=”default” max_width=”800px” global_colors_info=”{}”][\/dipi_breadcrumbs][et_pb_divider color=”#EEEEEE” _builder_version=”4.16″ _module_preset=”default” max_width=”800px” min_height=”1px” height=”20px” custom_margin=”||3px|||” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.18.0″ _module_preset=”8738c908-7375-4c6c-99a7-9f91f8a3c099″ header_font_size=”56px” max_width=”800px” custom_margin=”||||false|false” global_colors_info=”{}”]<\/p>\n

UBC\u00ae Rapid<\/h6>\n

Bladder Cancer detection.<\/h1>\n

IDL Biotech’s UBC\u00ae Rapid is a powerful Doctors-office test (Point-of-Care) for aid in diagnosis and monitoring of bladder cancer.<\/h5>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”e9afc0e7-c9bf-4a12-be49-63ddba231101″ custom_margin=”0px||||false|false” custom_padding=”30px||0px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” custom_padding=”||15px|||” global_colors_info=”{}”]<\/p>\n

UBC\u00ae Rapid<\/h3>\n

UBC\u00ae Rapid is a powerful Doctors-office test (Point-of-Care) to aid in diagnosing and monitoring bladder cancer patients in conjunction with standard diagnostic procedures<\/span>. The test measures soluble fragments of cytokeratin 8 and 18 in urine samples. It can easily be performed by a nurse or a technician with minimal training and the results are obtained within 10 minutes. Elevated amounts of cytokeratin protein fragments are present in the urine of individuals with bladder cancer, even at the early stages of the disease.<\/p>\n

UBC\u00ae Rapid shall be used for quantitative determination in combination with the POC-reader or concile\u00ae \u2126100.<\/p>\n

\u2013 The only quantitative POC test platform for urine-based detection of bladder cancer.
\u2013 Easy and rapid to perform \u2013 result within 10 minutes
\u2013 Works with haematuria<\/p>\n

IDL Biotech is the legal manufacturer of UBC\u00ae Rapid.<\/strong><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/04\/about-us.jpg” alt=”Ubc Rapid by arocell” title_text=”about us” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_toggle title=”Cytokeratin” disabled_on=”off|off|off” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Most eukaryotic cells have cytoplasmic cytoskeletal structures known as intermediate filaments. The cytoskeletal network is responsible for the mechanical integrity of the cell, and it is critical during cellular processes like cell division, motility and cell to cell contacts. At present more than 20 different cytokeratins have been identified, of which cytokeratin 8, 18, and 19 are the most abundant in simple epithelial cells. The cytokeratins are epithelial cell-specific and the cytokeratin pattern is usually preserved during the transformation of normal cells into malignant cells.<\/p>\n

Cytokeratins in cancer<\/h5>\n

Cancer affects everyone \u2013 the young and old, the rich and poor, men, women, and children \u2013 and represents a tremendous burden on patients, families, and societies. Cancer is one of the leading causes of death in the world.
Normal cells are constantly dividing, but in cancer, abnormal cell growth occurs. This causes the protein cytokeratin to leak out which can be measured with efficient diagnostic tools. Thanks to modern technology, AroCell can quickly diagnose several kinds of cancer non-invasive and pain-freely.<\/p>\n

[\/et_pb_toggle][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Find more information<\/h3>\n

UBC\u00ae Rapid is a powerful diagnostic parameter in aid of diagnosis and follow-up of bladder cancer, especially for papillary non-invasive high-grade tumors and carcinoma in situ (CIS).<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2026\/02\/UBC-rapid-folder-91-657-12.pdf” url_new_window=”on” button_text=”Download the broschure” _builder_version=”4.27.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Clinical evaluation<\/h3>\n

UBC\u00ae Rapid performs better than urine cytology in many patients due to improved sensitivity and the combination of UBC\u00ae Rapid and cytology enables detection of additional tumors as opposed to cytology alone.<\/p>\n

[\/et_pb_text][et_pb_toggle title=”References for UBC\u00ae Rapid” disabled_on=”off|off|off” _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

1. Giannopoulus A., et al. Comparative evaluation of the diagnostic performance of the BTA Stat test,NMP22 and Urinary\u00a0<\/a>Bladder Cancer antigen for primary and recurrent bladder tumors. J Urol 2001; 166:470-475.<\/p>\n

2.\u00a0<\/span>L\u00fcdecke G., et al. Comparative analysis of sensitivity to blood in the urine for urine-based point-of-care assays (UBC\u00ae<\/sup>\u00a0<\/span><\/a>Rapid, NMP22 BladderChek and BTA-stat) in primary diagnosis of bladder carcinoma. Interference of blood on the result of urine-based POC tests. Anticancer Res 2012; 32:2015-2018.<\/p>\n

3.\u00a0<\/span>Ritter R., et al. Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer.\u00a0<\/a>Urol Oncol 2014; 32:337-344.<\/p>\n

4.\u00a0<\/span>Ecke T., et al. Preliminary results of a multicentre-study of the UBC\u00ae<\/sup>\u00a0<\/span>Rapid for detection of urinary bladder cancer.\u00a0<\/a>Anticancer Res 2015; 35:2651-2656.<\/p>\n

5.\u00a0<\/span>Styrke J., et al. Evaluation of the diagnostic accuracy of UBC\u00ae<\/sup>\u00a0<\/span>Rapid in bladder cancer: a Swedish multicentre study.\u00a0<\/a>Scand J Urol 2017; 51:293-300.<\/p>\n

6.\u00a0<\/span>Ec<\/a>ke T., et al.\u00a0<\/a>UBC\u00ae<\/sup>\u00a0<\/span>Rapid Test for detection of carcinoma in situ (CIS) in urinary bladder cancer. Tumor Biol 2017; 39:1-7.<\/a><\/p>\n

7.\u00a0<\/span>Pichler R., et al. Urinary Rapid and NMP22 test for bladder cancer surveillance in comparison to urinary cytology: Results\u00a0<\/a>from a prospective single-center study. Int J Med Sci 2017; 14:811-819.<\/p>\n

8.\u00a0<\/span>Gleichenhagen J., et al. Evaluation of a new Survivin ELISA and UBC\u00ae<\/sup>\u00a0<\/span>Rapid for the detection of bladder cancer in urine.\u00a0<\/a>Int J Mol Sci 2018; 19:226-239<\/p>\n

9.\u00a0Ecke T., et al.\u00a0UBC\u00ae<\/sup>\u00a0Rapid\u00a0Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study.\u00a0Int J Mol Sci.\u00a02018 Dec 2;19(12)<\/a><\/p>\n

[\/et_pb_toggle][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” global_module=”3323″ saved_tabs=”all” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”51″ disabled_on=”on|on|off” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_menu][et_pb_sidebar area=”et_pb_widget_area_10″ disabled_on=”off|off|on” _builder_version=”4.18.0″ _module_preset=”2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74″ background_color=”#F8F8F8″ locked=”off” global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2365″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ make_equal=”on” _builder_version=”4.27.4″ _module_preset=”default” width=”90%” max_width=”2000px” global_colors_info=”{}”][et_pb_column type=”1_2″ module_class=”ds-vertical-align” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Oncology<\/h6>\n

Diagnostics for oncology<\/h3>\n

Cancer is one of the leading causes of death worldwide, despite advancing knowledge. To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/products\/oncology\/” button_text=”Read more about oncology” _builder_version=”4.22.1″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-sunset.jpeg” title_text=”Happy smiling running beagle dog portrait with tongue out and owner female jogging by the mounting meadow grass path. Walking in nature with pets, happy healthy active people lifestyle concept image.” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2428″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ make_equal=”on” _builder_version=”4.27.4″ _module_preset=”default” width=”90%” max_width=”2000px” global_colors_info=”{}”][et_pb_column type=”1_2″ module_class=”ds-vertical-align” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Bacteriology<\/h6>\n

An effective typhoid test<\/h3>\n

Typhoid fever is water and food-borne infectious disease caused by the bacterium, Salmonella<\/em> enterica. IDL Biotechs product TUBEX\u00ae TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/products\/bacteriology\/” button_text=”Read more about bacteriology” _builder_version=”4.18.0″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-water.jpeg” title_text=”Water is Life for African Children, Little Gorgeous Black Girl Drinking from Tap” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2175″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ make_equal=”on” _builder_version=”4.27.4″ _module_preset=”default” width=”90%” max_width=”2000px” global_colors_info=”{}”][et_pb_column type=”1_2″ module_class=”ds-vertical-align” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#21242A” global_colors_info=”{}”]<\/p>\n

Investors<\/h6>\n

We are listed on NASDAQ First North Growth Market.<\/h3>\n

We want to be the obvious choice within our segment in the markets where we are established. The market for our products is large and we are a smaller player with significant growth potential so far. IDL Diagnostics is unique for a company of this size.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/investors\/” button_text=”Read more about investing” _builder_version=”4.18.0″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/MG_3045.jpg” title_text=”_MG_3045″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n